UNSPSC 51131740: Ticagrelor

This classification denotes an antiplatelet agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GLH0314RVC. European Medicines Agency schedules Ticagrelor in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30898. Ticagrelor generally arises in the molecular formula C23H28F2N6O4S. The term TICAGRELOR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21, no. 1, 2007, list 57.) Most nations schedule ticagrelor under HS 29335990 and SITC 51576.

As of Q4 2014, TICAGRELOR remains the US FDA Preferred Term for this commodity. Ticagrelor bears US NLM identifiers UMLS ID C1999375 and NCI Concept Code C76404. SMILES: CCCSC1=NC2=C(C(=N1)NC3CC3C4=CC(=C(C=C4)F)F)N=NN2C5CC(C(C5O)O)OCCO.

UNSPSC 51131740 Ticagrelor, a Commodity code, shows no recent state and local procurement activity aligned with its pharmaceutical scope. The single recent opportunity tagged under this code—Sourcewell RFP #061626, posted May 12, 2026 with a June 16, 2026 response deadline—solicits law enforcement equipment on behalf of a multi-state cooperative purchasing vehicle, not pharmaceuticals or ticagrelor specifically. The mismatch between the code's nominal product (an antiplatelet drug) and the actual solicitation suggests either a data-entry error in the state and local procurement system or a miscategorization in the source record.

Without documented recent activity in the actual scope of UNSPSC 51131740, state and local business development should treat this code as dormant for procurement purposes at this time. The cooperative purchasing vehicle Sourcewell does solicit broadly across product and service categories on behalf of Washington counties and participating entities nationwide, but no current opportunities in pharmaceutical procurement or ticagrelor are evident in the available records.